{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:20:43Z","timestamp":1793830843637,"version":"4.6.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.forsciint.2018.11.018","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T17:40:19Z","timestamp":1543254019000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Use of the Randox Evidence Investigator immunoassay system for near-body drug screening during post-mortem examination in 261 forensic cases"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2622-3328","authenticated-orcid":false,"given":"Poppy","family":"McLaughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-9658","authenticated-orcid":false,"given":"Peter D.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Pounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Osselton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2018.11.018_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jflm.2011.06.006","article-title":"Perceptions of near virtual autopsies","volume":"18","author":"Rutty","year":"2011","journal-title":"J. Forensic Legal Med."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00194-006-0408-9","article-title":"Are autopsies necessary?: The role of computed tomography as a possible alternative to invasive autopsies","volume":"17","author":"Rutty","year":"2007","journal-title":"Rechtsmedizine"},{"key":"10.1016\/j.forsciint.2018.11.018_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(11)61483-9","article-title":"Post mortem imaging as an alternative autopsy in the diagnosis of adult deaths: a validation study","volume":"379","author":"Roberts","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.forsciint.2018.11.018_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: practical guide for clinicians","volume":"86","author":"Moeller","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.forsciint.2007.03.008","article-title":"The U.S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations","volume":"174","author":"Bush","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36076\/ppj.2010\/13\/E1","article-title":"Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectrometry (LC\/MS\/MS)","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"key":"10.1016\/j.forsciint.2018.11.018_bib0035","series-title":"Clarke\u2019s Analysis of Drugs and Poisons","first-page":"73","article-title":"Workplace drug testing","author":"Verstraete","year":"2011"},{"key":"10.1016\/j.forsciint.2018.11.018_bib0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jemermed.2011.01.031","article-title":"Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department","volume":"42","author":"Attema-de Jonge","year":"2012","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11419-009-0071-4","article-title":"Application of the Cozart DDS system to postmortem screening of drugs of abuse in vitreous humor","volume":"27","author":"Fernandez","year":"2009","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11419-012-0149-2","article-title":"Real-time near-body drug screening during autopsy. 1: Use of the Randox biochip drugs of abuse DOA I and DOA II immunoassays","volume":"31","author":"McLaughlin","year":"2013","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0055","first-page":"280","article-title":"Applications of an HPLC-DAD drug screening system based on retention indices and UV spectra","volume":"22","author":"Elliott","year":"1988","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2018.11.018_bib0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-60761-459-3_4","article-title":"Identification and quantitation of amphetamine, methamphetamine, MDMA, pseudoephedrine, and ephedrine in blood, plasma, and serum using gas chromatography\u2013mass spectrometry (GC\/MS)","volume":"603","author":"Gunn","year":"2010","journal-title":"Clin Appl Mass Spectrom"},{"issue":"5","key":"10.1016\/j.forsciint.2018.11.018_bib0065","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"},{"key":"10.1016\/j.forsciint.2018.11.018_bib0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.legalmed.2008.01.002","article-title":"Phencyclidine and cannabinoids in vitreous humor","volume":"10","author":"Jenkins","year":"2008","journal-title":"Legal Med"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073818310405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073818310405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T08:21:38Z","timestamp":1717230098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073818310405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":14,"alternative-id":["S0379073818310405"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2018.11.018","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the Randox Evidence Investigator immunoassay system for near-body drug screening during post-mortem examination in 261 forensic cases","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2018.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}